Enliven Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 13,000 | $2.48 | $32,240 | 36,000 | Dec 22, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $16.84 | $84,200 | 897,688 | Dec 19, 2025 |
| Kunkel Lori Anne | — | Option Exercise | 15,958 | $1.12 | $17,873 | 30,712 | Dec 17, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 1,705 | $21.78 | $37,135 | 263,311 | Dec 8, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 492 | $23.09 | $11,360 | 902,688 | Nov 19, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 12,500 | $21.82 | $272,750 | 890,392 | Nov 17, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 613 | $17.94 | $10,997 | 269,974 | Nov 7, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 12,500 | $22.08 | $276,000 | 915,188 | Oct 20, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 12,500 | $21.33 | $266,625 | 902,892 | Oct 17, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,667 | $20.10 | $134,007 | 276,641 | Oct 7, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 3,250 | $2.48 | $8,060 | 26,250 | Sep 29, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 4,000 | $20.25 | $81,000 | 927,688 | Sep 26, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 3,700 | $20.06 | $74,222 | 915,392 | Sep 26, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 1,500 | $20.03 | $30,045 | 931,688 | Sep 23, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 2,800 | $20.03 | $56,084 | 919,092 | Sep 23, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 2,130 | $20.02 | $42,643 | 933,188 | Sep 19, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 5,000 | $19.09 | $95,450 | 922,892 | Sep 19, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,667 | $20.24 | $134,940 | 283,308 | Sep 8, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 3,250 | $2.48 | $8,060 | 26,250 | Aug 27, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 1,517 | $20.00 | $30,340 | 927,892 | Aug 20, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 7,500 | $20.01 | $150,075 | 940,188 | Aug 19, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 590 | $20.00 | $11,800 | 929,409 | Aug 18, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,262 | $18.20 | $113,968 | 290,380 | Aug 7, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 3,185 | $20.45 | $65,133 | 23,065 | Jul 28, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 576 | $22.90 | $13,190 | 952,688 | Jul 21, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 3,663 | $23.37 | $85,604 | 940,392 | Jul 17, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 1,000 | $22.66 | $22,660 | 23,000 | Jul 10, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,362 | $19.75 | $125,650 | 296,947 | Jul 7, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 198 | $21.66 | $4,289 | 23,000 | Jun 27, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 12,500 | $21.40 | $267,500 | 965,188 | Jun 20, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 1,998 | $22.75 | $45,455 | 952,892 | Jun 17, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 3,000 | $2.48 | $7,440 | 26,000 | Jun 13, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,607 | $20.33 | $134,320 | 303,369 | Jun 9, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 7,500 | $20.03 | $150,225 | 977,688 | Jun 3, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 7,500 | $20.05 | $150,375 | 965,392 | Jun 3, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 3,250 | $16.18 | $52,585 | 23,000 | May 27, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 5,000 | $16.31 | $81,550 | 985,188 | May 19, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 5,000 | $16.49 | $82,450 | 972,892 | May 19, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,173 | $18.30 | $112,966 | 310,470 | May 7, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 5,030 | $20.07 | $100,952 | 992,658 | May 2, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 5,330 | $20.08 | $107,026 | 980,062 | May 2, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 69 | $19.12 | $1,319 | 23,000 | Apr 28, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 4,670 | $16.03 | $74,860 | 998,018 | Apr 21, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 5,000 | $16.42 | $82,100 | 985,392 | Apr 17, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 2,763 | $18.29 | $50,535 | 316,791 | Apr 7, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option Exercise | 3,250 | $2.48 | $8,060 | 26,250 | Mar 27, 2025 |
| Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sale | 1,000 | $22.50 | $22,500 | 23,000 | Mar 24, 2025 |
| Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sale | 12,500 | $20.61 | $257,625 | 1,002,688 | Mar 19, 2025 |
| Kintz Samuel | PRESIDENT AND CEO | Sale | 12,500 | $20.83 | $260,375 | 990,392 | Mar 17, 2025 |
| Patel Anish | CHIEF OPERATING OFFICER | Sale | 6,667 | $21.44 | $142,940 | 323,310 | Mar 7, 2025 |